Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA IND. SWIFT SHUKRA PHARMA/
IND. SWIFT
 
P/E (TTM) x 19.3 3.3 579.7% View Chart
P/BV x 14.1 - - View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   IND. SWIFT
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
IND. SWIFT
Mar-23
SHUKRA PHARMA/
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs8915 606.3%   
Low Rs117 171.1%   
Sales per share (Unadj.) Rs53.775.9 70.7%  
Earnings per share (Unadj.) Rs4.04.8 83.6%  
Cash flow per share (Unadj.) Rs5.710.1 56.4%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.1-130.1 -17.7%  
Shares outstanding (eoy) m10.9654.16 20.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.90.1 667.7%   
Avg P/E ratio x12.42.2 564.8%  
P/CF ratio (eoy) x8.81.0 837.5%  
Price / Book Value ratio x2.2-0.1 -2,662.9%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m547572 95.6%   
No. of employees `000NANA-   
Total wages/salary Rs m44637 6.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5884,110 14.3%  
Other income Rs m12119 10.1%   
Total revenues Rs m6004,228 14.2%   
Gross profit Rs m541,026 5.2%  
Depreciation Rs m18287 6.4%   
Interest Rs m3598 0.5%   
Profit before tax Rs m44260 17.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m44260 16.9%  
Gross profit margin %9.125.0 36.5%  
Effective tax rate %0.80-   
Net profit margin %7.56.3 118.2%  
BALANCE SHEET DATA
Current assets Rs m5312,734 19.4%   
Current liabilities Rs m4259,363 4.5%   
Net working cap to sales %18.0-161.3 -11.1%  
Current ratio x1.20.3 427.6%  
Inventory Days Days0115 0.0%  
Debtors Days Days1,873929 201.6%  
Net fixed assets Rs m2193,758 5.8%   
Share capital Rs m39108 36.1%   
"Free" reserves Rs m214-7,155 -3.0%   
Net worth Rs m253-7,047 -3.6%   
Long term debt Rs m384,031 0.9%   
Total assets Rs m7506,492 11.5%  
Interest coverage x16.81.4 1,170.7%   
Debt to equity ratio x0.1-0.6 -26.0%  
Sales to assets ratio x0.80.6 124.0%   
Return on assets %6.313.2 47.3%  
Return on equity %17.4-3.7 -471.5%  
Return on capital %16.2-28.4 -57.1%  
Exports to sales %068.8 0.0%   
Imports to sales %05.3 0.0%   
Exports (fob) Rs mNA2,827 0.0%   
Imports (cif) Rs mNA217 0.0%   
Fx inflow Rs m02,947 0.0%   
Fx outflow Rs m0313 0.0%   
Net fx Rs m02,634 0.0%   
CASH FLOW
From Operations Rs m32730 4.3%  
From Investments Rs m-44-293 15.1%  
From Financial Activity Rs m49-466 -10.6%  
Net Cashflow Rs m37-29 -129.0%  

Share Holding

Indian Promoters % 51.0 55.6 91.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 44.4 110.4%  
Shareholders   10,963 14,219 77.1%  
Pledged promoter(s) holding % 0.0 42.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs IND. SWIFT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs IND. SWIFT Share Price Performance

Period RELISH PHARMA IND. SWIFT S&P BSE HEALTHCARE
1-Day -2.00% 8.28% 1.18%
1-Month 18.32% -2.97% -0.75%
1-Year 528.10% 161.80% 61.82%
3-Year CAGR 229.50% 59.03% 18.16%
5-Year CAGR 114.18% 27.79% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the IND. SWIFT share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of IND. SWIFT the stake stands at 55.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of IND. SWIFT.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

IND. SWIFT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of IND. SWIFT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.